Neuralink logo next to a circular device with thin wires on a black and white background
ARGENTINA

Blindsight: this is Neuralink's chip that would allow seeing in infrared

Neuralink will begin implanting its Blindsight chip in humans. It promises to cure blindness and enhance human vision

Neuralink plans to begin implanting its new chipBlindsight in humans within the next 6 to 12 months. The goal is to restore vision, even in people who have been blind since birth, and enhance it with capabilities such as seeing in infrared or ultraviolet.

The project aims to open the door to a new form of augmented vision that could change human perception as we know it.

Neuralink device disassembled into several pieces on a black background next to the company logo
Neuralink plans to begin implanting its new Blindsight chip in humans | La Derecha Diario

What is Blindsight and how does it work?

Blindsight is a brain implant designed by Neuralink to connect the brain's visual cortex directly to a technological interface. This eliminates the need for the optic nerve to function properly.

The idea is to generate a digital image that the brain can interpret, even in people who have never seen. The first version would provide blurry vision, which will be improved over time.

"Like having superpowers"

According to Elon Musk, Blindsight could allow people to see spectrums such as infrared or ultraviolet, creating an unprecedented sensory experience. "It's like having superpowers," he stated in an interview with the media outlet Neo Niche.

Short dark-haired man wearing a black tuxedo with a white jersey and bow tie, looking back with a serious expression at an elegant event
Blindsight could allow people to see spectra such as infrared or ultraviolet | La Derecha Diario

He believes this technology will be key for what he defines as "cognitive enhancement". A way to boost human intelligence and senses beyond their biological limits.

Neuralink has already tested Blindsight in monkeys

During 2024, the company tested preliminary versions of the chip in monkeys, which led to protests from animal rights organizations and an investigation by U.S. health authorities.

Neuralink logo in white on a dark background with blurred red lights
Neuralink has already tested Blindsight on monkeys | La Derecha Diario

Despite the controversies, the FDA recognized Blindsight as an innovative device. This allows its clinical research to be accelerated and progress toward the first human trials.

A new stage for Neuralink

This announcement comes after Neuralink's first successful trials with human patients, who managed to control a cursor with their minds. The first implant had failures, but the company corrected course in subsequent cases.

➡️ Argentina

More posts: